Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

ABSTRACT: The main purpose of this study is to assess the safety and tolerability and to determine the recommended phase 2 dose of S 95005 given in combination with oxaliplatin in patients with metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms,Cancer

PROVIDER: 2220986 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR